Semaglutide works by mimicking the effects of GLP-1 (glucagon-like peptide-1), a naturally occurring hormone that plays a key role in regulating blood sugar and appetite
Moreover, this improvement was observed across all major symptoms of DPN, including pain, paresthesia and numbness [105, 106]
Still, wellness influencers primarily based in the US have been promoting the benefits of experimentally injecting GLP-1s
It is only trending because it shows visibly fast results and will be more accessible, both of which are perfectly fine in today's time where everyone wants things quickly
What Medicares Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries The Centers for Medicare & Medicaid Services (CMS) has released a memo fleshing out the design of a short-term program providing Medicare coverage of GLP-1s for obesity in 2026 ahead of a multi-year demonstration program beginning in 2027
The middle lane in appetite control GLP-1 has become mainstream through drugs like Ozempic and Mounjaro that mimic a natural satiety signal and deliver striking weight loss